Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma.

RATIONALE Several studies published in the second half of the 1990s have shown a therapeutic early effect of inhaled corticosteroids in acute asthma. However, systemic corticosteroids are considered the standard of care. OBJECTIVES To compare the effect of repeated doses of inhaled fluticasone with the standard treatment of systemic corticosteroids in adult patients with severe acute asthma. METHODS One hundred six patients (mean age, 33.5 +/- 8.8 years) were randomly assigned to receive fluticasone (3,000 microg/hour) administered through a metered-dose inhaler and spacer at 10-minute intervals for 3 hours, or 500 mg of intravenous hydrocortisone. In addition, all patients received inhaled albuterol and ipratropium bromide. MAIN RESULTS Subjects treated with fluticasone showed 30.5 and 46.4% greater improvements in PEF and FEV1, respectively, compared with the hydrocortisone group. The fluticasone group had better PEF and FEV1 at 120, 150, and 180 minutes (p < 0.05). Also, the fluticasone group showed higher rates of patients who obtained the discharge threshold at 90, 120, and 150 minutes. This therapeutic benefit was particularly evident in those patients with the most severe obstruction. Subjects with a baseline FEV1 of less than 1 L treated with fluticasone showed a significant increase in pulmonary function (p = 0.001) and a significant decrease in hospitalization rate (p = 0.05). CONCLUSIONS The use of repeated doses of inhaled fluticasone was more effective than intravenous hydrocortisone and was associated with an early improvement. This therapeutic benefit was particularly evident in those patients with the most severe obstruction.

[1]  A. Wanner,et al.  Nongenomic actions of glucocorticosteroids on the airway vasculature in asthma. , 2004, Proceedings of the American Thoracic Society.

[2]  A. Wanner,et al.  Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[3]  I. Adcock,et al.  How Do Corticosteroids Work in Asthma? , 2003, Annals of Internal Medicine.

[4]  C. Rodrigo,et al.  Triple inhaled drug protocol for the treatment of acute severe asthma. , 2003, Chest.

[5]  I. Danta,et al.  Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids , 2003, European Respiratory Journal.

[6]  Martin Wehling,et al.  Nongenomic actions of steroid hormones , 2003, Nature Reviews Molecular Cell Biology.

[7]  C. Camargo,et al.  The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. , 2002, Annals of emergency medicine.

[8]  J. Barberà,et al.  Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma , 2002, European Respiratory Journal.

[9]  A. Wanner,et al.  Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects. , 2001, Journal of applied physiology.

[10]  B. Rowe,et al.  Early emergency department treatment of acute asthma with systemic corticosteroids. , 2001, The Cochrane database of systematic reviews.

[11]  M. Corey,et al.  A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. , 2000, The New England journal of medicine.

[12]  C. Rodrigo,et al.  First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. , 2000, American journal of respiratory and critical care medicine.

[13]  I. Danta,et al.  Transient effect of inhaled fluticasone on airway mucosal blood flow in subjects with and without asthma. , 2000, American journal of respiratory and critical care medicine.

[14]  S. Singhi,et al.  Inhaled budesonide in acute asthma , 1999, Journal of paediatrics and child health.

[15]  C. Rodrigo,et al.  Corticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation. , 1999, Chest.

[16]  S. Singhi,et al.  Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma , 1999, Acta paediatrica.

[17]  S. Shalitin,et al.  Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. , 1998, The Journal of allergy and clinical immunology.

[18]  G. Rappold,et al.  Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter , 1998, Nature Neuroscience.

[19]  C. Rodrigo,et al.  Inhaled flunisolide for acute severe asthma. , 1998, American journal of respiratory and critical care medicine.

[20]  McFadden Er,et al.  Inhaled glucocorticoids and acute asthma: therapeutic breakthrough or nonspecific effect? , 1998 .

[21]  M. Levy,et al.  Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. , 1996, Thorax.

[22]  M. Joffe,et al.  Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. , 1995, Annals of emergency medicine.